medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2024, Number 5

<< Back Next >>

Salud Mental 2024; 47 (5)

Pilot Feasibility Study of an Individualized Cognitive Rehabilitation Program in Mexican Adults with Mild Dementia

Aguilar-Navarro SG, Palacios-Hernández MGI, Ouvrard C, Gutiérrez-Gutiérrez LA, Mimenza-Alvarado AJ

Language: English
References: 42
Page: 239-248
PDF size: 325.44 Kb.


ABSTRACT

Introduction. Dementia is a global public health problem, for which there is currently no cure. The increasing number of non-pharmacological interventions for the management of dementia challenges us to provide evidence- based care. Objective. To evaluate the feasibility of an individualized, cognitive rehabilitation program based on the French ETNA3 trial in Mexican subjects over fifty-five with mild Alzheimer's dementia and their caregivers who live in the community. Method. Non-randomized feasibility study. The intervention consisted of a twelve-month cognitive rehabilitation program, divided into eighteen ninety-minute sessions, administered by trained psychologists, and standardized according to the French ETNA3 program. To assess its feasibility, we determined the percentage of eligibility, acceptability, retention, and compliance and evaluated the adverse effects and degree of satisfaction in patients and their caregivers. Results. Thirty-two people with dementia and their caregivers agreed to participate. The mean age of the participants was 80 ± 8 years, the majority (72%) were women, and 78% had had five or more years of schooling. At twelve months, twenty-eight subjects (87%) completed the program with 100% compliance with the scheduled sessions. Discussion. This study shows the feasibility of an individualized cognitive rehabilitation program based on ETNA3 for Mexican subjects with mild dementia and their caregivers. Conclusion. More studies are required to evaluate the importance of trained therapists and caregiver support in achieving significant cognitive and functional changes in patients.


REFERENCES

  1. Aguilar-Navarro, S. G., Mimenza-Alvarado, A. J., Palacios-García, A. A., Samudio-Cruz, A., Gutiérrez-Gutiérrez, L. A., & Ávila-Funes, J. A. (2018). Validityand Reliability of the Spanish Version of the Montreal Cognitive Assessment(MoCA) for the Detection of Cognitive Impairment in Mexico [Validez yconfiabilidad del MoCA (Montreal Cognitive Assessment) para el tamizaje deldeterioro cognoscitivo en México]. Revista Colombiana de Psiquiatría, 47(4), 237-243. https://doi.org/10.1016/j.rcp.2017.05.003

  2. Alzheimer’s Association. (2016). 2016 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia, 12(4), 459-509. https://doi.org/10.1016/j.jalz.2016.03.001

  3. Amieva, H., Robert, P. H., Grandoulier, A. S., Meillon, C., De Rotrou, J., Andrieu,S., Berr, C., Desgranges, B., Dubois, B., Girtanner, C., Joël, M.-E., Lavallart,B., Nourhashemi, F., Pasquier, F., Rainfray, M., Touchon, J., Chêne, G., &Dartigues, J.-F. (2016). Group and individual cognitive therapies in Alzheimer’sdisease: the ETNA3 randomized trial. International Psychogeriatrics, 28(5),707-717. https://doi.org/10.1017/s1041610215001830

  4. Amieva, H., Robert, P. H., Grandoulier, A. S., Meillon, C., De Rotrou, J., Andrieu,S., … Dartigues, J. F. (2008, March 28 – 2013, August 1). Group and individualcognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial.National Library of Medicine. Identifier NCT00646269. https://classic.clinicaltrials.gov/ct2/show/NCT00646269

  5. Aravena, J. M., Gajardo, J., Saguez, R., Hinton, L., & Gitlin, L. N. (2022).Nonpharmacologic Interventions for Family Caregivers of People Living WithDementia in Latin-America: A Scoping Review. American Journal of GeriatricPsychiatry, 30(8), 859-877. https://doi.org/10.1016/j.jagp.2021.10.013

  6. Bahar-Fuchs, A., Clare, L., & Woods, B. (2013). Cognitive training and cognitiverehabilitation for mild to moderate Alzheimer’s disease and vascular dementia.Cochrane Database of Systematic Reviews, 2013(6), CD003260. https://doi.org/10.1002/14651858.cd003260.pub2

  7. Berg-Weger, M., & Stewart, D. B. (2017). Non-Pharmacologic Interventions forPersons with Dementia. Missouri Medicine, 114(2), 116-119.

  8. Blampied, N. M. (1999). A legacy neglected: Restating the case for single-caseresearch in cognitive-behaviour therapy. Behaviour Change, 16(2), 89-104.https://doi.org/10.1375/bech.16.2.89

  9. Choi, J., & Twamley, E. W. (2013). Cognitive Rehabilitation Therapies forAlzheimer’s Disease: A Review of Methods to Improve Treatment Engagementand Self-Efficacy. Neuropsychology Review, 23(1), 48-62. https://doi.org/10.1007/s11065-013-9227-4

  10. Clare, L., Wilson, B. A., Carter, G., Roth, I., & Hodges, J. R. (2004). Awarenessin Early-Stage Alzheimer’s Disease: Relationship to Outcome of CognitiveRehabilitation. Journal of Clinical and Experimental Neuropsychology, 26(2),215-226. https://doi.org/10.1076/jcen.26.2.215.2808810.

  11. Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A.,& Gornbein, J. (1994). The Neuropsychiatric Inventory: Comprehensiveassessment of psychopathology in dementia. Neurology, 44(12), 2308-2314.https://doi.org/10.1212/wnl.44.12.2308

  12. Custodio, N., Lira, D., Herrera-Perez, E., Nuñez Del Prado, L., Parodi, J., Guevara-Silva, E., Castro-Suarez, S., Mar, M., Montesinos, R., & Cortijo, P. (2014).Informal caregiver burden in middle-income countries: Results from MemoryCenters in Lima-Peru. Dementia & Neuropsychologia, 8(4), 376-383. https://doi.org/10.1590/S1980-57642014DN84000012

  13. DeTure, M. A., & Dickson, D. W. (2019). The neuropathological diagnosis ofAlzheimer’s disease. Molecular Neurodegeneration, 14(1), 32. https://doi.org/10.1186/s13024-019-0333-5

  14. Dexter, F. (2013). Wilcoxon-Mann-Whitney test used for data that are not normallydistributed. Anesthesia and Analgesia, 117(3), 537-538. https://doi.org/10.1213/ANE.0b013e31829ed28f

  15. 15 Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”: Apractical method for grading the cognitive state of patients for the clinician.Journal of Psychiatric Research, 12(3), 189-198. https://doi.org/10.1016/0022-3956(75)90026-6

  16. Freitas, S., Simões, M. R., Alves, L., & Santana, I. (2013). Montreal cognitiveassessment: validation study for mild cognitive impairment and Alzheimerdisease. Alzheimer Disease and Associated Disorders, 27(1), 37-43. https://doi.org/10.1097/WAD.0b013e3182420bfe

  17. Gebrie, M. H., & Ford, J., (2019). Depressive symptoms and dietary non-adherenceamong end stage renal disease patients undergoing hemodialysis therapy:systematic review. BMC Nephrology, 20(1), 429. https://doi.org/10.1186/s12882-019-1622-5

  18. Gélinas, I., Gauthier, L., McIntyre, M., & Gauthier, S. (1999). Development of aFunctional Measure for Persons With Alzheimer’s Disease: The DisabilityAssessment for Dementia. The American Journal of Occupational Therapy,53(5), 471-481. https://doi.org/10.5014/ajot.53.5.471

  19. Hachinski, V., Oveisgharan, S., Romney, A. K., & Shankle, W. R. (2012). Optimizingthe Hachinski Ischemic Scale. Archives of Neurology, 69(2), 169-175. https://doi.org/10.1001/archneurol.2011.1698

  20. Huang, H. C., Chen, Y. T., Chen, P. Y., Huey-Lan Hu, S., Liu, F., Kuo, Y. L., & Chiu, H.Y. (2015). Reminiscence Therapy Improves Cognitive Functions and ReducesDepressive Symptoms in Elderly People With Dementia: A Meta-Analysis ofRandomized Controlled Trials. Journal of the American Medical DirectorsAssociation, 16(12), 1087-1094. https://doi.org/10.1016/j.jamda.2015.07.010

  21. Hubbard, G., O’Carroll, R., Munro, J., Mutrie, N., Haw, S., Mason, H., & Treweek,S. (2016). The feasibility and acceptability of trial procedures for a pragmaticrandomised controlled trial of a structured physical activity intervention forpeople diagnosed with colorectal cancer: findings from a pilot trial of cardiacrehabilitation versus usual care (no rehabilitation) with an embedded qualitativestudy. Pilot and Feasibility Studies, 2, 51. https://doi.org/10.1186/s40814-016-0090-y

  22. Jeong, J. H., Na, H. R., Choi, S. H., Kim, J., Na, D. L., Seo, S. W., Chin, J., Park,S. A., Kim, E.-J., Han, H. J., Han, S.-H., Yoon, S. J., Lee, J.-H., Park, K. W.,Moon, S. Y., Park, M. H., Choi, M. S., Han, I.-W., Lee, J. H., ... Kim, J. Y.(2016). Group- and Home-Based Cognitive Intervention for Patients with MildCognitive Impairment: A Randomized Controlled Trial. Psychotherapy andPsychosomatics, 85(4), 198-207. https://doi.org/10.1159/000442261

  23. Kurth, S., Wojtasik, V., Lekeu, F., Quittre, A., Olivier, C., Godichard, V., Bastin,C., & Salmon, E. (2021). Efficacy of Cogitive Rehabilitation Versus UsualTreatment at Home in Patients With Early Stages of Alzheimer Disease.Journal of Geriatric Psychiatry and Neurology, 34(3), 209-215. https://doi.org/10.1177/0891988720924721

  24. Livingston, G., Kelly, L., Lewis-Holmes, E., Baio, G., Morris, S., Patel, N., Omar,R. Z., Katona, C., & Cooper, C. (2014). Non-pharmacological interventionsfor agitation in dementia: systematic review of randomised controlled trials.British Journal of Psychiatry, 205(6), 436-442. https://doi.org/10.1192/bjp.bp.113.141119

  25. Logsdon, R. G., & Teri, L. (2018). Qualityof life in dementia: Conceptualization,measurement, and psychosocial treatment implications. In G. E. Smith &S. T. Farias (Eds.). APA Handbook of Dementia (pp. 237-248). https://doi.org/10.1037/0000076-012

  26. Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky,S. (2002). Prevalence of Neuropsychiatric Symptoms in Dementia and MildCognitive Impairment: results from the cardiovascular health study. JAMA,288(12), 1475-1483. https://doi.org/10.1001/jama.288.12.1475

  27. McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R.,Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs,R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, B.,Weintraub, S., & Phelps, C. H. (2011). The diagnosis of dementia due toAlzheimer’s disease: Recommendations from the National Institute on Aging‐Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’sdisease. Alzheimer’s & Dementia, 7(3), 263-269. https://doi.org/10.1016/j.jalz.2011.03.005

  28. Meyer, C., & O’Keefe, F. (2018). Non-pharmacological interventions for peoplewith dementia: A review of reviews. Dementia, 19(6), 1927-1954. https://doi.org/10.1177/1471301218813234

  29. Nichols, E., Steinmetz, J. D., Vollset, S. E., Fukutaki, K., Chalek, J., Abd-Allah, F.,Abdoli, A., Abualhasan, A., Abu-Gharbieh, E., Akram, T. T., Al Hamad, H.,Alahdab, F., Alanezi, F. M., Alipour, V., Almustanyir, S., Amu, H., Ansari, I.,Arabloo, J., Ashraf, T., ... Vos, T. (2022). Estimation of the global prevalence ofdementia in 2019 and forecasted prevalence in 2050: an analysis for the GlobalBurden of Disease Study 2019. The Lancet Public Health, 7(2), e105-e125.https://doi.org/10.1016/s2468-2667(21)00249-8

  30. Nitrini, R., Barbosa, M. T., Dozzi-Brucki, S. M., Yassuda, M. S., & Caramelli, P.(2020). Current trends and challenges on dementia management and researchin Latin America. Journal of Global Health, 10(1), 010362. https://doi.org/10.7189/jogh.10.010362

  31. Orsmond, G. I., & Cohn, E. S. (2015). The Distinctive Features of a FeasibilityStudy: Objectives and Guiding Questions. OTJR: Occupation, Participationand Health, 35(3), 169-177. https://doi.org/10.1177/1539449215578649

  32. Petriwskyj, A., Parker, D., Brown-Wilson, C., & Gibson, A. (2016). Evaluation ofSubscription-based Culture Change Models in Care Settings: Findings From aSystematic Review. The Gerontologist, 56(4), e46-e62. https://doi.org/10.1093/geront/gnw012

  33. Ralph, S. J., & Espinet, A. J. (2018). Increased All-Cause Mortality by AntipsychoticDrugs: Updated Review and Meta-Analysis in Dementia and General MentalHealth Care. Journal of Alzheimer’s Disease Reports, 2(1), 1-26. https://doi.org/10.3233/adr-170042

  34. Sachdev, P. S., Blacker, D., Blazer, D. G., Ganguli, M., Jeste, D. V., Paulsen, J. S.,& Petersen, R. C. (2014). Classifying neurocognitive disorders: the DSM-5approach. Nature Reviews Neurology, 10(11), 634-642. https://doi.org/10.1038/nrneurol.2014.181

  35. Shigihara, Y., Hoshi, H., Shinada, K., Okada, T., & Kamada, H. (2020). Nonpharmacologicaltreatment changes brain activity in patients with dementia.Scientific Reports, 10(1), 6744. https://doi.org/10.1038/s41598-020-63881-0

  36. Thomas, G. (2011). A typology for the case study in social science following a reviewof definition, discourse, and structure. Qualitative Inquiry, 17(6), 511-521.https://doi.org/10.1177/1077800411409884

  37. Trivedi, R. B., Szarka, J. G., Beaver, K., Brousseau, K., Nevins, E., Yancy, W. S., Slade,A., & Voils, C. I. (2013). Recruitment and retention rates in behavioral trialsinvolving patients and a support person: A systematic review. ContemporaryClinical Trials, 36(1), 307-318. https://doi.org/10.1016/j.cct.2013.07.009

  38. Wang, L. Y., Pei, J., Zhan, Y. J., & Cai, Y. W. (2020). Overview of Meta-Analysesof Five Non-pharmacological Interventions for Alzheimer’s Disease. Frontiersin Aging Neuroscience, 12, 594432. https://doi.org/10.3389/fnagi.2020.594432

  39. Wigfield, A., & Eccles, J. S. (2000). Expectancy–Value Theory of AchievementMotivation. Contemporary Educational Psychology, 25(1), 68-81. https://doi.org/10.1006/ceps.1999.1015

  40. Wilson, B. A. (2002). Towards a comprehensive model of cognitiverehabilitation. Neuropsychological Rehabilitation, 12(2), 97-110. https://doi.org/10.1080/09602010244000020

  41. Yesavage, J. A., Brink, T., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O.(1982). Development and validation of a geriatric depression screening scale:A preliminary report. Journal of Psychiatric Research, 17(1), 37-49. https://doi.org/10.1016/0022-3956(82)90033-4

  42. Zarit, S. H., Todd, P. A., & Zarit, J. M. (1986). Subjective Burden of Husbands andWives as Caregivers: A Longitudinal Study. The Gerontologist, 26(3), 260-266.https://doi.org/10.1093/geront/26.3.260.




2020     |     www.medigraphic.com